Users will soon be able to view health records on iPhones with Apple’s improved Health app

Apple device users will now have a better way to log and document their health with improvements made in iOS 10, the operating system for the tech giant's mobile devices.

Currently, the Health App on iOS 9 allows users to track their steps, track sleep and nutrition and create a medical ID that can be accessed by physicians in case of an emergency.

But with the upgraded app, which is set to debut this fall when iOS 10 launches, users will be able to upload and store health records in the app, making it more convenient to track paperwork from their providers. Electronic health records (EHRs) an be imported from the Mail app, Safari, Dropbox and other compatible applications.

Additionally, other additions to Apple’s HealthKit in iOS 10 include the ability to specify workout routines and the location and weather conditions at the time of them.

For more information on other new features in iOS 10, click here.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.